Effect of Lactobacillus acidophilus supernatants on body weight and leptin expression in rats by Renato Sousa et al.
BioMed Central
BMC Complementary and 
Alternative Medicine
ssOpen AcceResearch article
Effect of Lactobacillus acidophilus supernatants on body weight and 
leptin expression in rats
Renato Sousa1, Jaroslava Halper*1, Jian Zhang1, Stephen J Lewis2 and Wan-
I O Li2
Address: 1Department of Pathology, College of Veterinary Medicine, The University of Georgia, Athens, GA 30602, USA and 2Department of 
Physiology/Pharmacology, College of Veterinary Medicine, The University of Georgia, Athens, GA 30602, USA
Email: Renato Sousa - renato@uga.edu; Jaroslava Halper* - jhalper@vet.uga.edu; Jian Zhang - juliazh@uga.edu; 
Stephen J Lewis - steve@galleonpharma.com; Wan-I O Li - oliverli@vet.uga.edu
* Corresponding author    
Abstract
Background: Lactobacillus extracts and supernatants have been used as probiotics in human and
veterinary medicine for their ability to enhance wound healing and immunity. Previous data from
our laboratory demonstrated that Lactobacillus supernatant (LS) stimulated wound healing,
angiogenesis and proliferation of embryonic cells after topical application. This current study shows
that LS after its administration into the cerebral ventricles of male rats exerts systemic effects.
Methods: The right lateral cerebral ventricle of young male rats was accessed through
intracerebroventricular cannulation (ICV) under anesthesia and aseptic conditions. One group of
control rats received saline solution, a second control group received 0.8 M lactic acid solution (to
control for acidity of LS), and a third group received LS. The animals were sacrificed 12, 24, 48, 96
and 120 hours after the injection. Selected tissues were collected, fixed in 10% buffered formalin
and used for immunohistochemistry and in situ hybridization. Other tissues were frozen and
extracted for immunoblotting
Results: LS-injected animals had a slight decrease in body weight when compared to their initial
weight and to both control groups. Using immunohistochemistry and in situ hybridization leptin
expression was studied in multiple brain sections and peripheral adipose tissue of control and LS-
injected rats. Strong cytoplasmic stain was observed by both techniques in neurons of the cerebral
cortex, thalamus, hypothalamus, hippocampus and, to lesser degree, in the cells of the choroid
plexus in the LS-injected rats. Control animals demonstrated much less intense staining in neurons
located in the same regions using immunohistochemistry and almost no staining with in situ
hybridization technique. Adipose tissue exhibited slight presence of leptin in LS-treated animals. In
contrast no immunohistochemical staining for GM-CSF and TNFα was observed in brains from
control and treated rats. Western blotting showed mild increase in leptin and leptin receptors in
intestines and retroperitoneal adipose tissues of LS-injected rats.
Conclusion: This study demonstrates that direct administration of LS into rat CNS leads to a
decrease in body weight of rats and an increase in the expression of leptin in specific areas of the
brain and retroperitoneal adipose tissue.
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Lactobacilli are non-pathogenic Gram-positive lactic acid
bacteria found in the normal intestinal microflora of ani-
mals and humans [1] and are classified as probiotic
agents. Lactobacillus derived products, including culture
supernatants have been used for their wound healing and
antiviral properties as they are believed to boost energy
and to be effective remedies for allergies, common cold,
lactose intolerance, and have also been shown to reduce
cholesterol levels and the risk of colon cancer [2-4]. Super-
natants of Lactobacillus acidophilus were also proved to be
effective against Helicobacter pylori in vitro and in vivo in
people and were shown to possess antimicrobial activities
against Bacillus anthracis and E. coli [3]. Our previous data
have shown that Lactobacillus supernatants (LS) promote
inflammatory response during tissue repair in rodents [5],
stimulate proliferation of embryonic cells [6], and that
subcutaneous injections of Lactobacillus supernatants into
the ears of rats lead to angiogenesis [5]. Using a cytokine
antibody array, leptin and several other cytokines (e.g., IL-
6, IL-8 and TGFβ) were detected in medium conditioned
by bovine endothelial cells exposed to LS (data not
shown).
This study represents a continuation of our previous work
[5]. The purpose was to identify whether LS stimulates
angiogenesis in rodent CNS and/or expression of leptin in
rodents. Leptin, the product of the obese gene (ob or lepob)
is a 16 kDa non-glycosylated protein well known for its
effects on the reduction of body weight and involvement
in certain aspects of wound healing, such as angiogenesis.
Leptin acts in the central nervous system through binding
to leptin receptors located in the hypothalamus, particu-
larly in the arcuate nucleus and by coordinating metabo-
lism, feeding behavior, energy balance and
neuroendocrine responses [7-9]. In addition to CNS lep-
tin is also expressed in adipocytes, placenta [10], mam-
mary gland [11], pituitary glands [12], and stomach [13].
In experiments designed to determine whether the super-
natants elicit angiogenesis in the cerebral circulation, we
injected LS into the lateral cerebral ventricles of adult, nor-
motensive Sprague-Dawley rats. A vital serendipitous
finding was that the injection led to reductions in body
weight without changes in body temperature or intake of
food and water. This was accompanied by increased leptin
expression in CNS, and intestinal and retroperitoneal adi-
pose tissue.
Methods
Preparation of supernatants from Lactobacillus cultures
Briefly, cultures of L. acidophilus (ATCC strains 4356 and
43121) were grown in MRS broth (pH 5.5; Difco Labora-
tories, Detroit, MI) at 37°C for 24 hr under microaer-
ophilic conditions. This medium contains a rich nutrient
base as well as polysorbate, acetate, magnesium, and
manganese, which are known to promote the growth and
proliferation of Lactobacilli. Overnight bacterial cultures
contained 2.5 × 108 colony-forming units, and these cul-
tures were centrifuged at 10,000 g for 15 min at 4°C. The
resulting supernatants were filtered through a 0.2-µm
membrane filter to remove the remaining bacteria and
debris, lyophilized, and then stored at -20°C. At the time
of the experiments, the lyophilized LS was reconstituted
with deionized water, filtered with puradiscs (0.22- µm
pore size; Whatman Inc., Ann Arbor, MI) and termed LS.
The pH of LS was 2.35 + 0.15, and osmolality was 320
mOsm.
Animals
The use of animals and the animal experiments was
approved by the Animal Use Committee at The University
of Georgia. Thirty eight young male Sprague Dawley rats
(Harlan, Sprague Dawley, Inc., Indianapolis, IN) ranging
in weight from 250 to 350 g (or 6–8 weeks of age) at the
beginning of the experiment were used. The animals were
housed individually in a temperature-controlled room
(22 ± 1°C) with a 12 h-12 h light-dark cycle. Food and
water were available ad libitum in their cages. Body param-
eters such as rectal temperature and body weight were
checked daily, as was food and water consumption. At the
end of each experiment rats were euthanized by CO2 over-
dose.
Intra-cerebroventricular cannulation
Intracerebroventricular (ICV) cannulations were per-
formed under anesthesia and aseptic conditions. The right
lateral cerebral ventricle was accessed. The rats, weighing
between 250 and 350 g, were anesthetized intra-muscu-
larly with 0.2 ml/100 g of a mixture composed of acepro-
mazine (5 mg (0.5 ml) of 10 mg/ml), ketamine (150 mg
(1.5 ml) of 100 mg/ml and xylazine (30 mg (1.5 ml) of 20
mg/ml). The dorsum of the head was shaved and rats were
placed in a stereotaxic holding device. The skin was disin-
fected with 70% isopropyl alcohol and a 22-gauge guide
cannula (c313G – Single guide cannula, Plastics One, Inc.,
Roanoke, VA), cut to a length of 15 mm, was implanted
into the right lateral ventricle. The stereotaxic coordinates
used were with respect to the bregma, AP = -0.8 mm, L = -
1.4 mm and depth = 15 mm below the skull surface. The
cannula was held in place with three stainless-steel screws
and dental cement on the skull. A 32-gauge dummy can-
nula (c313DC – Single guide cannula, Plastics One, Inc.)
cut at 12 mm was inserted when the rat was not receiving
an injection. Rats were allowed 1 week to recover, when
they were expected to recover their initial body, presented
when the day the surgery was performed. The rats were
divided into 3 groups and sterile saline solution, LS solu-
tion, and 0.8 M lactic acid solution were administered.Page 2 of 8
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One week after the establishment of ICV cannulation, 0.2
µl of saline solution (n = 9), 0.8 M lactic acid solution (n
= 7) or LS (n = 22) were injected using a 10 µl Hamilton
syringe connected to a catheter with a 28-gauge internal
cannula (c313I – Internal cannula, Plastics One, Inc.) cut
at 15 mm. The rats were kept for up to 120 hr and were
monitored for changes in behavior, body weight, temper-
ature, and food and water consumption at 0, 12, 24, 48,
96 and 120 hr after ICV injection. Rats receiving each solu-
tion were euthanized by CO2 inhalation after 12, 24, 48,
and in selected cases 120 hr after the ICV injection. The
entire brain, intestines and retroperitoneal adipose tissue
were collected immediately after euthanasia, fixed in 10%
buffered formalin for 24 hr and processed routinely for
histopathology.
Thirty eight young Sprague-Dawley male rats were divided
into 3 groups to study the potential effect of injection of
LS into the cerebral ventricles on angiogenesis of CNS
blood vessels. The experimental group (22) was adminis-
tered LS. One control group (9 rats) received saline solu-
tion. The second group (7 rats) received lactic acid to
exclude the possibility that low pH (the pH of LS is 2.35)
rather than specific components of LS was responsible for
any ensuing changes. The osmolality of the LS (320
mOsm) and lactic acid (250 mOsm) solution was compa-
rable. The osmolality had no effect in our in vitro experi-
ments [5,6] as it was immediately diluted at 200 ×. In the
in vivo experiments the dilution factor was likely compara-
ble, and we never noticed any immediate effect, including
focal necrosis, on morbidity of the animals in this study
or in our previous report describing angiogenesis in vivo
[5]. In the saline solution control group three rats were
injected and euthanized at 12 hr, and two rats at 24, 48,
and 120 hr in each experiment. In the lactic acid control
group 2 rats were injected and euthanized at 12, 24, and
48 hr, and one rat was euthanized at 120 hr post injection.
In the LS group, 5 rats were euthanized at 12 hr, 4 rats at
24 hr, 4 rats at 48 hr, 1 rat at 96 hr, and 8 rats at 120 hr.
Body weight and other indices were determined in all rats
at intervals of 12, 24, 48, 96 and 120 hr after ICV injec-
tions until their euthanasia.
Immunohistochemistry
For immunohistochemistry a polyclonal antibody raised
in rabbits against the N-terminal region of leptin, the
product of the ob gene (Ob H-146, Santa Cruz Biotechnol-
ogy, Santa Cruz, CA, USA) was used as primary antibody
at 1:500 dilutions for 1 hr at 37°C after antigen retrieval
was performed in microwave for 10 min in Antigen
Unmasking Solution (Vector Laboratories, Burlingame,
CA, USA). The secondary antibody (anti-rabbit made in
goat from Roche Applied Sciences, Indianapolis, IN, USA)
was used in a 1:1000 dilution for 1 hr at 37°C. The slides
were then incubated with avidin-biotin complex (ABC)
method using Vectastain ABC kit (Vector) for 1 hr at
37°C.
Monoclonal rat antibody towards tumor necrosis factor α
(TNFα) (ab11564 from Abcam, Cambridge, MA, USA)
was used at 1:500 dilution, and monoclonal rat antibody
towards granulocyte-macrophage colony stimulating fac-
tor (GM-CSF) (MAB5181, R&D Systems, Minneapolis,
MN, USA) was used at 1:100 dilution. Anti-rat IgG from
Vector was used as a secondary antibody for both antibod-
ies at 1:250 for 1 hr at 37°C followed by color detection
using ABC-AP kit and alkaline phosphatase substrate SK-
5100 kit, both from Vector.
In situ hybridization assay
The riboprobe used for in situ hybridization was based on
the sequence of the rat leptin gene (Genbank accession
number D49653). A pair of primers was designed to cre-
ate a 422 bp long probe:
sense: 5'-TGT TCA AGC TGT GCC TAT CCA CAA AGT
CCA GGA-3'
antisense: 5'-GAA GAA TGT CCT GCA GAG AGC CCT
GCA GCC TG-3'
The mRNA was extracted from fresh rat fat with Trizol fol-
lowing manufacturer's instructions (Quiagen, Valencia,
CA, USA). The first strand of cDNA was synthesized using
Superscript III kit (Invitrogen, Carslbad, CA, USA) fol-
lowed by RT-PCR. After purification from an agarose gel
the PCR products were ligated into the TA- vector (pGEM-
Teasy, Promega, Madison, WI) and ligation products were
introduced into E. coli by heat-shock. Positive colonies
were confirmed by DNA sequencing performed by The
Sequencing and Synthesis Facility at University of Geor-
gia. A confirmed positive colony (it is in a reversed direc-
tion in pGEM-Teasy) was cultured and plasmid DNA
prepared using a Promega mini-prep kit. The resulting
constructs were cleaved with restriction enzyme SacI. This
was followed by in vitro transcription with T7 RNA
polymerase to generate an anti-sense RNA of approxi-
mately 422 bp nucleotides in length. Those anti-sense
riboprobes were used for in situ hybridization of formalin-
fixed, paraffin-embedded tissue samples to detect the pro-
duction of leptin in rat tissues.
Forward primer: 5'-TGT TCA AGC TGT GCC TAT CCA
CAA AGT CCA GGA-3' (sense)
Reverse primer: 5'-GAAGAATGTCCTGCAGAGAGCCCT-
GCAGCCTGC-3' (antisense)Page 3 of 8
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70°C for 10 min and deparafinized in Hemo-De. Tissue
sections were allowed to dry and then were rehydrated in
PBS + 5 mM MgCl2. Slides were incubated in Proteinase K
(100 µl/ml) diluted in proteinase K buffer (10 mM Tris
pH 7.5 + 2 mM CaCl2). The enzymatic reaction was
stopped with 0.1 M glycine + 0.2 M Tris, pH 7.5. Prehy-
bridization solution was added to sections for 1 hr
(42°C). This was followed by the addition of the probe (3
µl/slide) mixed with the prehybridization solution. A
total of 70 µl of probe + prehybridization solution/slide
was used and applying direct onto a siliconized coverslip,
which was sealed with nail hardener and kept in humid
chamber overnight (42°C).
The next day, after several washes the slides were incu-
bated with anti-dig AP diluted 1:300 in 2% normal serum
sheep in buffer1(150 mM NaCl + 100 mM Tris, pH 7.5)
for 2 hr. Slides were washed in buffers 1 and 3 (100 mM
NaCl + 100 mM Tris+ 50 mM MgCl2, pH 9.5) for 5 min.
Substrate (NBT + BCIP) was added and slides were
checked for staining. On average, the indicator color was
detected in brain tissues after 40 min and in adipose tissue
after 3 hr.
Western blotting
Intestines and retroperitoneal adipose tissues collected
from all three experimental groups were homogenized in
buffer composed of 20 mM Tris, 5 mM EDTA, 2 mM
Na3NO4, 10% glycerol, 1% Triton X-100 and 1 mM PMSF.
Aliquots of 10 µg protein were loaded per lane and sepa-
rated in 8% SDS-polyacrylamide gels, then transferred on
nitrocellulose membrane and with a polyclonal antibody
raised in rabbits against the N-terminal region of leptin,
the product of the ob gene (Ob H-146) or a polyclonal
antibody raised in rabbits against the leptin receptor (Ob-
R H-300, both from Santa Cruz Biotechnology) at 1:1000
dilutions. Antibody – antigen complexes were detected by
DAB kit (Vector).
Statistical analysis
One-way analysis of variance test using the General Linear
Models procedure of SAS was employed to test overall dif-
ferences between initial weight and weight at euthanasia
within LS-treated groups.
Results
Because our previous data have shown that topical admin-
istration of LS led to influx of inflammatory cells into skin
wound sites and to stimulation of angiogenesis in rodent
skin and subcutaneous tissues [5], we tested LS for the
ability to induce angiogenesis in the rat brain. No angio-
genesis was observed in brains of any of the rats, be it the
treatment or control groups. Neither was influx of inflam-
matory cells noted previously in subcutaneous tissues [5]
present anywhere in CNS. Instead the injection of LS elic-
ited reductions in body-weight. In comparison with the
control groups, the animals that received Lactobacillus
supernatants had a 24% decrease in body weight within
48 hours, and were able to sustain it at least up to 120 hr
(Table 1). A slight decrease in the body weight was
observed in the animals that received lactic acid (4.4%).
Because we did not have enough control rats for a statisti-
cal analysis at later time points (at 96 and 120 hr) we did
not perform it for evaluation body weight loss among the
three groups. However, Table 1 reveals a clear trend of loss
Table 1: Comparison of weight between control and LS-treated rats.
Time 0 h 12 h 24 h 48 h 96 h 120 h
Rats ID BW%
C1-C9 (n = 9) 100 99
C1-C6 (n = 6) 100 98.3 98.3
C1-C4 (n = 4) 100 98.3 98.7 95.6
C1-C2 (n = 2) 100 97.4 97.4 98.6 95.9 97.3
LA1-LA7 (n = 7) 100 97.7
LA1-LA5 (n = 5) 100 98.5 99.4
LA1-LA3 (n = 3) 100 98.5 98.3 99.5
LA1 (n = 1) 100 95.7 95.7 95.9 100.8 10.3.1
LS1-LS22 (n = 22) 100 94.9
LS1-LS17 (n = 17) 100 91.8 75.8
LS1-LS13 (n = 13) 100 94.8 92.9 75.1
LS1-LS8 (n = 9) 100 91.3 80.2 81.4 59.4
LS1-LS8 (n = 8) 100 94.9 85.8 79.8 63.1 65
• Control rats labeled C1-C9 received 0.2 µl of saline solution, rats C7-C9 were euthanized at 12 hr; C5-C6 were euthanized at 24 hr; C3-C4 were 
euthanized at 48 hr; C1-C2 were euthanized at 120 hr.
• Rats labeled LA1-LA7 received 0.2 µl of 0.8 M lactic acid solution; LA6- LA7 were euthanized at 12 hr; LA 4- LA 5 were euthanized at 24 hr; LA 
2- LA 3 were euthanized at 48 hr; LA 1 was euthanized at 120 hr.
• Rats labeled LS1-LS7 received 10 µl of LS, rats LS18- LS22 were euthanized at 12 hr; LS14- LS17 were euthanized at 24 hr; LS10- LS13 were 
euthanized at 48 hr; LS9 were euthanized at 96 hr; LS1-LS8 were euthanized at 120 hr.Page 4 of 8
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trol groups. One-way analysis of variance was used to
evaluate body weight loss within the LS-treated group
(Fig. 1). In this analysis body weight was measured on all
surviving rats at time points before their euthanasia. Our
data revealed significant difference in body weight
between 0 and 48 hr in rats treated with LS at α = 0.05
level (P-value = 0.084), between 0 and 96 hr (P-value =
0.0025) and between 0 and 120 hr (P-value = 0.0064).
Because LS caused marked increase in leptin production
in bovine endothelial cells and because leptin is involved
in regulation of body weight we hypothesized that LS
might also regulate leptin expression in the brain. We
employed both immunohistochemistry and in situ
hybridization to see whether LS injection leads to leptin
overexpression in the brain. Leptin expression was studied
in multiple brain sections of control and LS-injected rats.
Strong cytoplasmic stain was observed by both techniques
in neurons of the cerebral cortex, thalamus (Fig. 2),
hypothalamus and hippocampus (Fig. 3), and weaker
staining in the cells of the choroid plexus (data not
shown). Control animals demonstrated much less intense
staining in neurons (and other cells) located in the same
regions and tissues using immunohistochemistry and
almost no staining with in situ hybridization technique.
Peripheral adipocytes exhibited light immunostaining for
leptin in LS-injected rats (Fig. 4). Immunoblotting of pro-
tein extracts from intestines and from retroperitoneal adi-
pose tissue from LS-treated and control rats showed only
mild increase in both leptin and leptin receptor (data not
shown).
To see whether the effect on leptin synthesis was specific
we also performed immunohistochemistry for GM-CSF
and TNFα in CNS sections. In contrast no immunohisto-
chemical staining for GM-CSF and TNFα was observed in
brains from control and treated rats (data not shown),
though LS stimulated production of TNFα by several cell
lines [5]. Such results indicate that the effect of LS on lep-
tin expression is specific.
Discussion
We have shown that injection of LS into rat cerebral ven-
tricles led to decrease in body weight. This reduction was
independent of food and water intake and it occurred
concomitantly with a strong increase in leptin expression
in neurons of the cortical region, thalamus, hypothala-
mus, and hippocampus. Mild increase in leptin was noted
in the cells of the choroid plexus of the rat brain, and
peripheral tissues such as intestines and fat. This finding
was in contrast with our previous studies where local
administration of LS led to angiogenesis and influx of
inflammatory cells [5]. Interestingly, in a separate series of
experiments LS stimulated leptin secretion into medium
conditioned by bovine endothelial cells exposed to Lacto-
bacillus supernatants. We hypothesize that the kind of bio-
logical activity exerted by leptin depends on the tissue or
cell type serving as an LS target. It is also possible that dif-
ferential expression of other cytokines, induced by LS in
CNS and not yet identified, play a crucial role in modulat-
ing the effect of LS on body weight.
Several studies showed variable effects of Lactobacillus
extracts on the production of leptin or its plasma level.
The main reason for the discrepancy is the route of admin-
istration (ours is the only study where a Lactobacillus prep-
aration was administered directly into CNS), Lactobacillus
strain and/or animal species or breed used. Bleau et al. [1]
described Lactobacillus-induced decrease in leptin release
by adipocyte derived from SJL mice, whereas the same
Lactobacillus preparation led to an increase in leptin
release when used to treat C57BL/6 adipocytes. They
ascribed this to regulation of leptin synthesis by IL1β and
TNFα produced by C57BL/6 macrophages upon stimula-
tion by Lactobacillus preparation. In another report probi-
otic capsules containing L. acidophilus and Bifidobacterium
longum had no effect on plasma leptin in a group of men
even after 2 months of oral intake [14]. Oral administra-
tion of L. plantarum to smokers led to decrease in plasma
concentrations of leptin and other parameters which was
attributed to anti-inflammatory properties of L. plantarum
[15]. In contrast, our preparations of L. acidophilus do pro-
mote a variety of pro-inflammatory processes [5,6]. Some
of these processes (e.g., angiogenesis), though not all,
might be secondary to increased leptin expression. Our
previous data have shown that LS stimulates TNFα pro-
duction [5] which in turn would lead to increased leptin
expression [1]. This mechanism would be less likely to be
operational in CNS as immunohistochemistry did not
Average body weight of rats after intracerebroventricular injectionFigure 1
Average body weight of rats after intracerebroven-
tricular injection. ICV injection of LS led to statistically sig-
nificant decrease in body weight 48 hr and later after a single 
ICV injection. The groups 1–4 represent four experiments. 
*time points significantly different from 0 h at α = 0.05.
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Immunohistochemistry for leptin in brain tissueFigure 2
Immunohistochemistry for leptin in brain tissue. Rats injected with saline solution, lactic acid or LS were euthanized 48 
hr after injections and their brains were fixed in formalin immediately after euthanasia. Cytoplasmic immunostaining for leptin 
(arrows) was stronger in neurons of thalamus in LS-injected animals (B) than in corresponding cells of rats injected with saline 
(A). No counterstain. Magnification × 200.
In situ hybridization for leptinFigure 3
In situ hybridization for leptin. Rats injected with saline solution, lactic acid or LS were euthanized 48 hr after injections 
and their brains were fixed in formalin immediately after euthanasia. Leptin mRNA was visualized using in situ hybridization in 
sections of the brains of rats injected with saline solution (A, C), and LS extract (C, D). Leptin expression is observed in the 
cytoplasm of neurons in the hypothalamus (A, B; arrows) and hippocampus (C, D; arrows). Stronger expression is noted in LS-
injected animals. Light counterstain with hematoxylin. Magnification × 200.
BMC Complementary and Alternative Medicine 2008, 8:5 http://www.biomedcentral.com/1472-6882/8/5identify any TNFα in CNS of rats after LS injection in our
experiments.
We chose to look at the presence of GM-CSF and TNFα
(neither cytokine was included in the angiogenesis anti-
body array used by us) in the rat brain for several reasons.
GM-CSF was described to suppress food intake and reduce
body weight in rodents after intraventricular injection
[16]. In our experiments we found that food intake of LS-
injected rats was comparable to food intake of control ani-
mals and that no GM-CSF was present in rat CNS using
immunohistochemistry. TNFα, also known as cachectin,
leads to sometimes a significant weight loss. As men-
tioned above LS stimulates the production of TNFα in
peripheral macrophages [5] but not in CNS.
That leptin is primarily synthesized by adipocytes has
been known for many years [17]. Less well known but
well documented by many investigators has been the pro-
duction of leptin in the brain. For example, Wiesner et al.
have shown that leptin is released from the brain, particu-
larly in obese men [18]. Similarly to our findings, immu-
nostaining has localized leptin to many areas of the brain:
cortex, cerebellum, hypothalamus and hippocampus
[19]. In hypothalamus, leptin regulates energy intake and
expenditure [20], though some experiments point to lep-
tin signaling in caudal brainstem neurons as transmitting
gastrointestinal signals indicating satiety [21]. However,
leptin during fetal and neonatal period also modulates
brain development, especially in the hippocampus
[22,23] and hypothalamus [17]. It is thought that leptin
stimulates the proliferation and differentiation of neural
cell during early life as brain weight and DNA and protein
content are reduced in ob/ob (leptin-deficient) mice [24].
Conclusion
In conclusion, this study shows that direct administration
of LS into the brains of rats resulted in weight loss without
a decrease in food consumption. This was accompanied
an increase in leptin expression in neurons and peripheral
adipose tissues. The advantage (and a possible disadvan-
tage because of potential side effects) of LS use over puri-
fied leptin is the possibility that active components of LS
modulate the expression or release of other peptides
involved in metabolism and body weight control. The
identification and large scale testing of these compounds
is currently under investigation in our laboratory.
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